Oracle (ORCL) Stock Surges Following JPMorgan’s Overweight Rating and Massive Contract Backlog

Key Highlights

• JPMorgan assigned Oracle an Overweight rating with a $210 price objective, driving ORCL shares up 2.4% during pre-market hours
• The company secured a massive $30 billion cloud infrastructure agreement with the federal government in early 2026
• Third-quarter IaaS revenue reached $4.89 billion, representing an 84% annual increase; RPO skyrocketed to $553 billion
• Oracle exceeded Q3 projections with earnings per share of $1.79 compared to the anticipated $1.71, while revenue totaled $17.19 billion
• Wall Street analysts maintain a Moderate Buy consensus rating with an average target price of $261.46

Shares of Oracle (ORCL) advanced 2.4% during Wednesday’s pre-market session following JPMorgan’s decision to begin coverage with an Overweight designation and establish a $210 price objective.

Oracle Corporation, ORCL

JPMorgan analyst Mark Murphy highlighted a more favorable risk/reward dynamic, observing that market sentiment toward Oracle had shifted dramatically from “unwavering optimism to pervasive skepticism” regarding the company’s fiscal 2030 objectives — suggesting the negative sentiment may be overdone.

The general market context made Oracle’s performance particularly notable. With the S&P 500 trading flat, the Dow Jones showing minimal movement, and the Nasdaq essentially unchanged, Oracle’s gains stood out as company-specific momentum.

The timing of JPMorgan’s coverage initiation follows a transformative period for the enterprise software giant. Oracle finalized a $30 billion cloud infrastructure agreement with federal authorities in early 2026 — representing one of the most substantial cloud computing contracts in history.

This landmark agreement solidified Oracle’s role as a critical AI computing infrastructure provider for sensitive government operations, including national security and defense applications.

Compelling Financial Performance Supports Optimistic Outlook

Oracle’s latest quarterly financial disclosure provided substantial evidence supporting bullish analyst perspectives. The company delivered third-quarter earnings per share of $1.79, surpassing Wall Street’s $1.71 consensus forecast, while revenue reached $17.19 billion versus analyst expectations of $16.91 billion.

Total revenue climbed 21.7% compared to the prior-year period. Infrastructure as a Service revenue specifically totaled $4.89 billion, marking an impressive 84% year-over-year surge.

The most striking metric: Remaining Performance Obligations soared to $553 billion, representing a remarkable 325% annual increase. This enormous deferred revenue figure reflects substantial long-term AI-related contracts.

For the fourth quarter of 2026, Oracle projected earnings per share between $1.96 and $2.00, with full-year analyst consensus estimates settling at $6.08 per share.

Institutional Ownership Continues Strong

Huntington National Bank expanded its Oracle holdings by 0.6% during the fourth quarter, concluding the period with 672,225 shares representing approximately $131 million in market value.

Additional institutional investors joined the buying activity. Brighton Jones LLC dramatically increased its Oracle position by 189.3% in Q4, while both Revolve Wealth Partners and United Bank expanded their respective stakes. Institutional and hedge fund investors collectively control approximately 42.44% of outstanding shares.

Regarding insider transactions, Executive Vice President Stuart Levey divested 15,000 shares on April 16th at an average transaction price of $176.19, generating proceeds of $2.64 million. This disposition occurred pursuant to a predetermined Rule 10b5-1 trading arrangement.

Wedbush Securities recently elevated its Oracle price target from $225 to $275, reaffirming an Outperform recommendation. Meanwhile, Citigroup maintains a Buy rating with an ambitious $320 price objective.

The overall analyst community currently assigns Oracle 3 Strong Buy recommendations, 29 Buy ratings, 9 Hold ratings, and a single Sell rating. The consensus price target across analysts averages $261.46.

The stock has traded within a 52-week range spanning $134.57 to $345.72. Shares were changing hands near $190.73 prior to Wednesday’s pre-market advance.